{{Rsnum
|rsid=16856187
|Chromosome=2
|position=169770386
|Orientation=plus
|GMAF=0.135
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 98.2 | 1.8 | 0.0
| HCB | 46.7 | 44.5 | 8.8
| JPT | 34.5 | 46.9 | 18.6
| YRI | 78.2 | 21.1 | 0.7
| ASW | 84.2 | 12.3 | 3.5
| CHB | 46.7 | 44.5 | 8.8
| CHD | 45.9 | 45.0 | 9.2
| GIH | 81.2 | 18.8 | 0.0
| LWK | 64.2 | 31.2 | 4.6
| MEX | 94.8 | 5.2 | 0.0
| MKK | 60.9 | 34.6 | 4.5
| TSI | 97.1 | 2.9 | 0.0
| HapMapRevision=28
}}{{PMID|19082990}} [[type 2 diabetes]] and fasting plasma glucose concentration.

{{PMID Auto
|PMID=20628598
|Title=Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
|OA=1
}}

{{PMID Auto
|PMID=20668700
|Title=Effects of GCK, GCKR, G6PC2 and MTNR1B variants on glucose metabolism and insulin secretion.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}